Potential Molecular Predictors of Response to Novel Therapies in Metastatic Pancreatic Neuroendocrine Tumors
Clinical trial NCT01603004 · COMPLETED
Trial details
- NCT number
- NCT01603004
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2012-05-14
- Primary completion
- 2019-06-24
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.